STEM CELL TECHNOLOGY • 3D HUMAN TISSUE ENGINEERING • BIOINFORMATICS • REGENERATIVE MEDICINE BIOREPLICATE 3D HUMAN TISSUE MODELS SUPERIOR ALTERNATIVE TO ANIMAL TESTING STATE OF THE ART SCIENCE ®
STEM CELL TECHNOLOGY     3D HUMAN TISSUE ENGINEERING     BIOINFORMATICS     REGENERATIVE MEDICINE  BIOREPLICATE  3D HUMAN ...
BIOREPLICATE TECHNOLOGY BioReplicate 3D Human Tissue Model LIne: GRoK’s BioReplicate product line covers the biologic R&D industry spectrum, giving our clients a superior alternative to live animal models with which they can quickly, accurately, and cost effiecnly test safesty, efficacy, and toxicity of virtually any substance for human use.
BIOREPLICATE TECHNOLOGY BioReplicate 3D Human Tissue Model LIne  GRoK   s BioReplicate product line covers the biologic R ...
INDUSTRY ISSUES Unlike other 3D models, BioReplicate True 3D human tissue models maintain homeostais at the cellular level, sustain long term growth of cells and tissues, and allow for the preferential sensitization of cells for specific purposes, such as organ modeling and viral infectivity directed to vaccine development. BioReplicate True 3D Models Featuring Scionic Technology Scionic technology, which evolved from Dr. Goodwin’s patented capability of scientifically “tuning” electromagnetic fields, is a unique element of GRoK’s integrated system. It will be used to produce highly sensitive 3D tissue models in which genetic expression, celluar metabolism, and other activity within the cell can be regulated in a manner offered by no commercially aviailable in vitro model system. A significant issue in the conduct of virology research and vaccine development relates to achieving in the laboratory the infection of human tissues with certain dfficult to grow viruses. Using our Scionic technology to modulate celluar ion transport, GRoK can engineer human lung and other organ specific human tiusues that are “virus permissive,” thus rapidly accelerating virology research and vaccine development.
INDUSTRY ISSUES Unlike other 3D models, BioReplicate True 3D human tissue models maintain homeostais at the cellular level...
GROK SOLUTIONS In bioresearch, in vitro 3D cell cuture models are the most promising potential replacements for live animals for saftey, efficacy and toxicity testing. Based on their unique structual and functional characteristics, GRoK’s line of BioReplicate true 3D human tissue models are uniquely suited to meet these industry challenges today. BioReplicate true 3D human tissue models will be produced by with GRoK’s synthesized model assemply process, a combination of hardware, methodologies, and technqiues that prepresents the most sophisticated tissue assembly process in the emerging realm of 3D biology. 3D HUMAN TISSUE • • • • • • • • • • Adipose stem cells Adrenal gland Bladder Bone Brain Cardiac Muscle Carilage Colon Cord Blood Stem Cells Cornea • • • • • • • • • • Kidney Liver Lung Limphocytes Neural Stem Cells Pancreas Prostate Salivary Skin Small Intestine CANCER TISSUE • Bladder • Brain • Breast • Lung • Ovarian • Prostate • Colon • Gilioma • Kidney
GROK SOLUTIONS In bioresearch, in vitro 3D cell cuture models are the most promising potential replacements for live anima...
About GRoK GRoK Technologies LLC is a privately held, Houson-based, development-stage company founded to commercialize NASA life science and tissue engineering. Our products aim to advance biologic and drug research, vaccine production, functional protein production, and regenerative medicine research and treatment. GRoK’s technologies arise from NASA research and discoveries in microgravity, fluid suspension, and electromagnetism and their effects on human physiology at the cellular and genetic levels. Our technologies are built on the extensively peer-reviewed, published research and proven discoveries of Thomas J. Goodwin, PhD, former NASA celluar biolgiest, pioneer and leading authority in the areas of 3D biology, tissue engineering, bioelectromagnetic field effects, and synthesized tissue growth. Dr. Goodwin’s work spans more than 25 years in the field. He is a scientific advisor to GRoK and serves as Honorary President of the European Society for Translational Medicine (EUTSM). The GRoK intellectual property portfolio is supported by eight NASA licenses, granted exclusively to GRoK, covering 17 U.S. patents.The portfolio supports a robust product development and patenting pipeline. For access to our proof of principle and Peer-Reviewed research, visit: www.groktechnologies.com/bibliography
About GRoK GRoK Technologies LLC is a privately held, Houson-based, development-stage company founded to commercialize NAS...
GRoK Brochures StemReplicate Stem Cells & Research StemReplicate Stem Cell Expansion BioReplicate Virus Research & Vaccine Production BioReplicate True 3D Human Tissue Models BioReplicate Preclinical Trials CONTACT www.GRoKtechnologies.com U.S. 480.440.9700 | info@groktechnologies.com
GRoK Brochures StemReplicate Stem Cells   Research  StemReplicate Stem Cell Expansion  BioReplicate Virus Research   Vacci...